Determination and monitoring of bladder cancer

Details Determination and monitoring of bladder cancer Determination and monitoring of bladder cancer

G - Physics

01

N

G01N 33/76 (2006.01) G01N 33/574 (2006.01)

Patent

CA 2234253

A test method for determination of the presence of bladder cancer by determination of the urinary gonadotropin peptide (UGP) levels in no-blood body fluids is described. The method can also be used to monitor the course of bladder cancer and its treatment and the reoccurrance of the disease.

Méthode de test destinée à déterminer la présence d'un cancer de la vessie par détermination des niveaux de peptide gonadotrophine urinaire (UGP) dans des liquides biologiques autres que le sang. Le procédé peut également être utilisé pour suivre l'évolution d'un cancer de la vessie et son traitement ainsi que la récidive de la maladie.

Affiliated with

Also associated with

Rating

Determination and monitoring of bladder cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Determination and monitoring of bladder cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Determination and monitoring of bladder cancer will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2087842